Edition:
United States

Dr.Reddy's Laboratories Ltd (RDY.N)

RDY.N on New York Stock Exchange

43.65USD
3:30pm EDT
Change (% chg)

$-0.17 (-0.39%)
Prev Close
$43.82
Open
$43.85
Day's High
$43.99
Day's Low
$43.19
Volume
83,699
Avg. Vol
97,846
52-wk High
$68.00
52-wk Low
$40.74

Latest Key Developments (Source: Significant Developments)

Dr.Reddy's Laboratories Ltd - U.S. court imposes temporary sales ban on Dr Reddy's generic Nexium - Reuters
Tuesday, 10 Nov 2015 05:58am EST 

Dr.Reddy's Laboratories Ltd:Dr Reddy's Laboratories Ltd said on Tuesday it had been temporarily barred by a U.S. court from selling its generic form of blockbuster heartburn drug Nexium in the United States - RTRS.The order was passed by the U.S. district court of Delaware after AstraZeneca, the maker of Nexium, moved a motion objecting to the use of the colour purple in the Dr Reddy's copycat product, the Indian firm said in a statement - RTRS.The temporary restraining order has been imposed "with immediate effect on sales, delivery, transfer, or other disposition" of Dr Reddy's generic Nexium, the company said - RTRS.Dr Reddy's launched its generic Nexium in September after weeks of delay, as it had to shift production to a different plant after the U.S. Food and Drug Administration found quality control lapses at the original site - RTRS.  Full Article

Dr.Reddy's Laboratories Ltd's statement on receipt of warning letter from US FDA
Thursday, 5 Nov 2015 11:40pm EST 

Dr.Reddy's Laboratories Ltd:Acknowledged that it has received a warning letter issued by the US FDA dated Nov. 5, relating to its API manufacturing facilities at Srikakulam and Miryalaguda, as well as oncology formulation manufacturing facility at Duvvada, Visakhapatanam.Says this action follows the earlier inspections of these sites by agency in Nov. 2014, Jan. 2015 and Feb. 2015 respectively.  Full Article

Dr.Reddy's Laboratories Ltd to buy IP rights of Alchemia's fondparinux drug
Monday, 28 Sep 2015 04:38am EDT 

Dr.Reddy's Laboratories Ltd:Announces to buy IP rights of Alchemia's fondaparinux drug for 116 cr Indian Rupees.  Full Article

Dr.Reddy's Laboratories Ltd Announces the Launch of Esomeprazole Magnesium Delayed-Release Capsules USP, 20 mg and 40 mg
Monday, 28 Sep 2015 01:25am EDT 

Dr.Reddy's Laboratories Ltd:Says it has launched ESOMEPRAZOLE MAGNESIUM DELAYED-RELEASE CAPSULES USP, 20 mg and 40 mg, a therapeutic equivalent generic version of NEXIUM Delayed-Release Capsules in the US market on September 25, 2015, following the approval by the United States Food & Drug Administration (USFDA).  Full Article

Dr.Reddy's Laboratories Ltd signs commercialization deal with Hatchtech
Monday, 14 Sep 2015 12:31am EDT 

Dr.Reddy's Laboratories Ltd:Announces signing of a commercialization deal with Hatchtech United States, Canada, India, Russia and the CIS, Australia, New Zealand and Venezuela.Says the exclusive rights for this product are applicable for the territories of the.  Full Article

PanTheryx and Dr.Reddy's announce an agreement to market PanTheryx's Proprietary Nutritional Intervention for Pediatric Infectious Diarrhea
Tuesday, 8 Sep 2015 09:30pm EDT 

Dr.Reddy's Laboratories Ltd and PanTheryx Inc:Announces a multi-country supply and licensing agreement.The agreement grants the exclusive right to market and distribute PanTheryx's breakthrough nutritional intervention, DiaResQ (reg), for infectious diarrhea in India, Nepal, Russia, Myanmar, Vietnam, Ukraine, Sri Lanka, Kazakhstan, Belarus, Jamaica, and select LATAM markets.Says Dr. Reddy's will market the product in India and Nepal under the 'Reliqua' brand.  Full Article

Dr.Reddy's Laboratories Ltd voluntarily recalled a few batches of Amlodipine besylate and Atorvastatin from US market
Sunday, 6 Sep 2015 08:00pm EDT 

Dr.Reddy's Laboratories Ltd:Says has voluntarily recalled a few batches of amlodipine besylate and atorvastatin from the US market - Reuters.Says the impact of recall is not material.  Full Article

Dr.Reddy's Laboratories Ltd launches MINTOP PRO - Procapil Hair Therapy
Friday, 4 Sep 2015 07:13am EDT 

Dr.Reddy's Laboratories Ltd:Has announced its entry into the Hair Serum Market with the launch of MINTOP PRO - Procapil Hair Therapy.  Full Article

Dr.Reddy's Laboratories Ltd announces the Launch of PRAMIPEXOLE Dihydrochloride Extended-Release Tablets
Wednesday, 12 Aug 2015 07:58am EDT 

Dr.Reddy's Laboratories Ltd:Announces the Launch of PRAMIPEXOLE Dihydrochloride Extended-Release Tablets 0.375 mg, 0.75 mg, 1.5 mg, and 4.5 mg a therapeutic equivalent generic version of MIRAPEXER, Extended-Release Tablets in the US market on Aug. 11.  Full Article

Dr.Reddy's Laboratories Ltd announces strategic collaboration with Amgen in India
Thursday, 6 Aug 2015 12:33am EDT 

Dr.Reddy's Laboratories Ltd:Announces strategic collaboration with Amgen in India.Eneters into a strategic collaboration to market and distribute three Amgen medicines in India in the areas of oncology and cardiology.  Full Article

India's Dr Reddy's in $350 million deal to buy eight U.S. drugs from Teva, Allergan

MUMBAI India's second-largest drugmaker Dr Reddy's Laboratories Ltd said it agreed to buy eight generic drugs from Teva Pharmaceutical Industries and Allergan Plc for $350 million in cash to bolster its U.S. business.